anmelden
OMX Nordic 40
2.718,06
PKT
+10,11
PKT
+0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.07.26 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 16.07.26 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.07.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 16.07.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 15.07.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 14.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.07.26 | Novo Nordisk Neutral | UBS AG | |
| 13.07.26 | AstraZeneca Buy | UBS AG | |
| 13.07.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 13.07.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.07.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 10.07.26 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 10.07.26 | AstraZeneca Outperform | Bernstein Research | |
| 09.07.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 09.07.26 | AstraZeneca Outperform | Bernstein Research | |
| 09.07.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.07.26 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.07.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 09.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.07.26 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 08.07.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.07.26 | Volvo (B) Underweight | Barclays Capital | |
| 07.07.26 | Volvo (B) Buy | UBS AG | |
| 07.07.26 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 06.07.26 | AstraZeneca Outperform | Bernstein Research | |
| 03.07.26 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 03.07.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 02.07.26 | Nokia Neutral | UBS AG | |
| 01.07.26 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 30.06.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.06.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.06.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 30.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.06.26 | Nokia Buy | Jefferies & Company Inc. | |
| 30.06.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 29.06.26 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 29.06.26 | Nokia Underweight | Barclays Capital | |
| 29.06.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.06.26 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 26.06.26 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG |
